Related by context. All words. (Click for frequent words.) 69 imetelstat 69 oral prodrug 69 PSMA ADC 69 PEG SN# 68 AQ4N 68 Gleevec resistant 68 CYT# potent vascular disrupting 67 Panzem R NCD 67 Capesaris 67 alefacept 67 HCD# [002] 67 HuLuc# 67 GRNVAC1 67 liposomal formulation 67 HGS ETR2 67 CCX# 67 teduglutide 67 alkylating agent 67 novel VDA molecule 67 MEK inhibitor 67 relapsed MM 67 Dasatinib 67 dacetuzumab 67 gamma secretase inhibitor 67 ONTAK 67 Interferon alpha 67 systemically administered 66 MAGE A3 ASCI 66 receptor tyrosine kinase inhibitor 66 rHuPH# 66 AeroLEF TM 66 AKT inhibitor 66 MAXY G# 66 corticosteroid dexamethasone 66 FUSILEV enhances 66 talabostat 66 bortezomib Velcade 66 ALN TTR 66 gemcitabine cisplatin 66 concurrent chemoradiation 66 Vidofludimus 66 TELINTRA 66 TLK# 66 fumagillin nanoparticles 66 Neulasta ® 66 paclitaxel Taxol 66 elotuzumab 66 microtubule inhibitor 66 ZOLINZA 66 gefitinib Iressa 66 Exherin TM 66 glucagon receptor 66 GRN#L 66 antiandrogen 66 rituximab Rituxan 66 lapatinib Tykerb 66 protein kinase inhibitor 66 docetaxel Taxotere ® 66 S/GSK# 66 vidofludimus 66 Onconase 66 fosbretabulin 66 GLP toxicology studies 66 budesonide foam 66 Amrubicin 66 metaglidasen 66 evaluating tivozanib 66 uric acid lowering 66 pegylated liposomal doxorubicin 66 oblimersen 66 CEQ# 66 TKM ApoB 66 PRT# 66 sargramostim 66 liposomal doxorubicin 66 histone deacetylase inhibitor 66 mTOR inhibitors 66 CDK inhibitor 65 DAVANAT 65 HGS# 65 interleukin IL -# 65 Trastuzumab 65 Tarceva TM 65 Preclinical studies suggest 65 ATL# [001] 65 ENMD # 65 CBLC# 65 erlotinib Tarceva 65 pegfilgrastim 65 immunomodulator 65 selective modulator 65 Traficet EN 65 lenalidomide Revlimid R 65 DXL# 65 Valortim ® 65 Kahalalide F 65 antiangiogenic agents 65 HGS ETR1 65 Vidaza ® 65 alvespimycin 65 MGd 65 generation purine nucleoside 65 calcitonin 65 OMP #M# 65 Androxal TM 65 Degarelix 65 PLK1 SNALP 65 Triapine R 65 PI3K/mTOR 65 sitaxsentan 65 nucleoside analog 65 antimetabolite 65 INCB# [001] 65 pharmacodynamic PD 65 Cleviprex TM clevidipine 65 Phase IIb clinical trials 65 forodesine 65 Xanafide 65 goserelin 65 Chemophase 65 IAP inhibitor 65 favorable pharmacokinetic profile 65 histamine dihydrochloride 65 APOPTONE 65 Vfend 65 Virulizin ® 65 paclitaxel Taxol ® 65 ApoB SNALP 65 apoptosis inducer 65 CD# CEA 65 cytotoxic effects 65 gastrointestinal stromal tumors GIST 65 Tumor Response 65 IFN α 65 adalimumab Humira 65 potently inhibited 65 antiangiogenic therapy 65 demonstrated antitumor activity 65 HGS ETR1 mapatumumab 65 retaspimycin 65 HuMax EGFr 65 preclinical toxicology 65 cisplatin resistant 65 ISTODAX 65 interferon ribavirin 65 tylosin 65 ESBA# 65 bevacizumab Avastin R 65 immune modulating 64 EGFR HER2 64 Myocet 64 Phase IIa trials 64 etoposide 64 protein tyrosine phosphatase 1B 64 rxRNA 64 antimetabolites 64 HYLENEX recombinant 64 efaproxiral 64 pharmacodynamic markers 64 atacicept 64 CIMZIA ™ 64 Orally administered 64 visilizumab 64 OvaRex R 64 NOD SCID mice 64 intravesical instillation 64 Omacetaxine 64 EDARBI 64 OncoVEX GM CSF 64 lenalidomide dexamethasone 64 EndoTAG TM -1 64 XL# XL# 64 Phase #b/#a trial 64 uricase 64 Pertuzumab 64 Cloretazine 64 APTIVUS r 64 lanthanum carbonate 64 CG# [003] 64 vinorelbine tartrate 64 dasatinib Sprycel 64 Azedra 64 Pharmacokinetic studies 64 CR# vcMMAE 64 MyVax R 64 Squalamine 64 Dacogen decitabine 64 MYDICAR ® 64 TG# [003] 64 depsipeptide 64 syngeneic 64 Spiegelmer ® 64 aurora kinase 64 velafermin 64 administered subcutaneously 64 mecamylamine 64 CIMZIA TM 64 LEP ETU 64 hMG 64 antitumor effects 64 PDE4 inhibitor 64 Th2 cytokines 64 Darinaparsin 64 huC# DM4 64 hA# 64 androgen independent 64 busulfan 64 CORT # 64 caspofungin 64 gemcitabine Gemzar ® 64 metastatic malignant 64 Ontak 64 Alkeran 64 Immunotherapeutic 64 bleomycin 64 HuMax CD4 64 targeted antifolate 64 XP# XP# 64 menadione 64 mapatumumab 64 TAKSTA 64 G#DT 64 multicenter Phase II 64 refractory prostate cancer 64 PBMCs 64 cannabinor 64 Protexia ® 64 EZN 64 estramustine 64 receptor inhibitor 64 xenograft models 64 Factor VIIa 64 SERMs 64 doxorubicin cyclophosphamide 64 Marqibo TM 64 Mitomycin C 64 BAL# [002] 64 Valortim R 64 pyrazinamide 64 oral picoplatin 64 CRLX# 64 anticancer compound 64 antiproliferative effects 64 tolevamer 64 erlotinib Tarceva ® 64 #I TM# 64 AMEVIVE 64 tumor necrosis 64 chemotherapy induced neutropenia 64 OHR/AVR# 64 mTOR inhibition 64 RLY# 64 Gliadel Wafer 64 IFN gamma 64 Zorbtive TM 64 AEG# 64 Solazed 64 OXi# 64 nalbuphine ER 64 IFN alpha 64 GAMMAGARD 64 paclitaxel poliglumex 64 anti Parkinsonian 64 milatuzumab 64 lomitapide 64 Proellex TM 64 Phase 1a clinical 64 itraconazole Sporanox 64 ALV# 63 Pemetrexed 63 ganetespib 63 dosing frequency 63 Elotuzumab 63 pathophysiological effects 63 Targretin capsules 63 thalidomide Thalomid 63 Virulizin R 63 idarubicin 63 antitumor effect 63 LHRH receptor positive 63 anti CD3 63 immunomodulatory properties 63 cetuximab Erbitux R 63 PXD# 63 Trofex 63 Anthim 63 reslizumab 63 EOquin TM 63 Cloretazine R VNP#M 63 AERx ® 63 eniluracil 63 NNRTI resistant virus 63 bexarotene 63 Tarvacin TM 63 HQK 63 acetonide FA 63 ChronVac C R 63 Bortezomib 63 etanercept Enbrel 63 nucleotide analog 63 YONDELIS 63 r hGH 63 investigational monoclonal antibody 63 taxane resistant 63 dose cohort 63 GnRH agonist 63 Fludara 63 mertansine 63 murine model 63 XOMA 3AB 63 Belerofon 63 verteporfin 63 lumiliximab 63 tumor xenograft models 63 BNC# 63 HCV replicon 63 Azacitidine 63 urocortin 2 63 indibulin 63 Actilon 63 kidney urologic 63 Exemestane 63 Panzem 63 Platinol ® cisplatin 63 zoledronate 63 #ME# 63 GAMMAGARD LIQUID 63 erythropoietic 63 inhibited tumor 63 ulimorelin 63 viral kinetics 63 CA4P 63 biliary tract cancer 63 plasma kallikrein inhibitor 63 pediatric acute lymphoblastic 63 letrozole Femara 63 telomerase inhibitor drug 63 orally dosed 63 Alzhemed TM 63 pomalidomide 63 Granulocyte Colony Stimulating Factor 63 immune modulatory 63 nucleoside analogs 63 LNCaP cells 63 cilengitide 63 mGluR5 NAM 63 docetaxel Taxotere R 63 inhibitory effects 63 Losartan 63 ALN TTR# 63 tyrosine kinase inhibitor 63 sorafenib Nexavar 63 Octreotide 63 salmeterol fluticasone 63 Alocrest 63 IFN beta 63 experimental autoimmune encephalomyelitis 63 ritonavir boosted 63 antitumor efficacy 63 coadministration 63 SPRYCEL ® 63 antiviral efficacy 63 Kinoid 63 GHRH 63 subcutaneously injected 63 novel emulsion formulation 63 Protexia R 63 radiolabeled monoclonal antibody 63 ALGRX 63 iobenguane 63 cyclophosphamide chemotherapy 63 selectively inhibited 63 torsemide ER 63 AAG geldanamycin analog 63 pharmacokinetic parameters 63 cMET 63 Teriparatide 63 Fulvestrant 63 docetaxel chemotherapy 63 humanized monoclonal antibodies 63 squalamine 63 prescribed proton pump 63 Neuradiab 63 mediated inhibition 63 flavopiridol 63 Taxol paclitaxel 63 galiximab 63 subcutaneous SC 63 anticancer agent 63 enzyme inhibitor 63 viral titers 63 Sudhir Agrawal D.Phil 63 JAK inhibitor 63 preclinically 63 teriflunomide 63 Aplidin R 63 APTIVUS 63 ANAVEX #-# [001] 63 PSN# [002] 63 5 FU leucovorin 63 maximally tolerated dose 63 cytotoxic therapies 63 HCV polymerase 63 MYCAMINE 63 huN# DM1 63 hypoxia activated prodrug 63 cisplatin gemcitabine 63 HCV protease inhibitor 63 Pegylated 63 antidiabetic 63 mu opioid receptor antagonist 63 Phase 2a trial 63 afamelanotide 63 Amplimexon 63 proteasome inhibitor 63 CHOP chemotherapy 63 Pharmacokinetics PK 63 EOquin 63 nab paclitaxel 63 Hsp# Inhibitor 63 Dapagliflozin 63 PI3K inhibitor 63 plasmid encoding 63 anti CD3 antibody 63 desvenlafaxine succinate 63 AZT zidovudine Retrovir 63 PKC# 63 Panzem R 63 Cloretazine R 63 BrachySil TM 62 therapeutic regimens 62 AMD# [003] 62 EGFR tyrosine kinase inhibitors 62 telomerase inhibition 62 subcutaneous formulation 62 ceftazidime 62 Pegylated Interferon 62 factor G CSF 62 PHX# 62 prostanoid 62 bicifadine 62 temsirolimus Torisel ® 62 dexamethasone Decadron 62 Thalomid ® 62 NF kB Decoy 62 antisense inhibition 62 EVIZON TM 62 adecatumumab 62 4mg/kg 62 Bendamustine 62 IMP# 62 Interferon Beta 62 endostatin 62 epoetin alpha 62 inhaled treprostinil 62 conventional DMARDs 62 immuno modulatory 62 intradermal injection 62 Irinotecan 62 targeting PCSK9 62 GW# [003] 62 relapsed ovarian cancer 62 Bruton tyrosine kinase Btk 62 inhaled iloprost 62 immunosuppressant drug 62 rhIL 7 62 Gleevec imatinib mesylate 62 Zemplar Capsules 62 Aurora Kinase 62 5 HT2C receptor 62 subcutaneously administered 62 vinca alkaloid 62 FK# 62 SNT MC# 62 NS5A 62 CTCE 62 JAK2 inhibitor 62 oral rivaroxaban 62 HCV protease inhibitors 62 Angiotensin Converting Enzyme 62 ORENCIA R 62 intradermal injections 62 personalized immunotherapy 62 omega interferon 62 Tyrima 62 FOSRENOL ® 62 novel anticancer 62 VELCADE melphalan 62 azacytidine 62 Decitabine 62 ImmunoVEX HSV2 62 anti angiogenic agent 62 infliximab Remicade 62 ERK1 2 62 weekly subcutaneous injections 62 amikacin 62 Glypromate 62 NXL# 62 mitoxantrone plus 62 investigational humanized monoclonal antibody 62 MCSP respectively 62 Cytotoxic 62 TNF Tumor Necrosis Factor 62 dorzolamide 62 octreotide implant 62 Cimzia TM 62 standard chemotherapy regimen 62 castrate resistant 62 Aplidin 62 EFAPROXYN 62 ALN PCS 62 PEGylated anti 62 LT NS# 62 Bezielle 62 phase IIb trial 62 posaconazole 62 RNAi therapeutic targeting 62 riociguat 62 CoFactor 62 topical ophthalmic 62 dihydrochloride 62 cetuximab Erbitux ® 62 Xelox 62 EGFR TKIs 62 denileukin diftitox 62 antisense inhibitors 62 ALK inhibitors 62 azoles 62 cediranib 62 complete cytogenetic response 62 Anidulafungin 62 faropenem 62 mesylate 62 novel peptide 62 Erlotinib 62 Dalbavancin 62 ancrod 62 bendamustine 62 dosing cohort 62 recurrent glioblastoma multiforme 62 Indomethacin 62 5FU 62 paclitaxel Taxol R 62 immunotoxin 62 ONCASPAR 62 interferon gamma 1b 62 vascular disrupting agents 62 nitazoxanide 62 dasatinib Sprycel ® 62 Azedra TM 62 androgen receptor AR 62 XL# inhibits 62 A1PI 62 Apoptone 62 SinuNase TM 62 pharmacokinetic PK study 62 clodronate 62 nutlin 3a 62 intranasal formulation 62 bovine thrombin 62 ascending dose 62 USL# 62 Alequel 62 pertuzumab 62 chimeric monoclonal antibody 62 steroid dexamethasone 62 PROCHYMAL 62 AGILECT R 62 topically administered 62 VNP#M 62 Etoposide 62 interferon γ 62 oxaliplatin Eloxatin 62 pain palliation 62 palifermin 62 DermaVir 62 cinacalcet 62 cytoprotective 62 NEUMUNE 62 convenient dosing regimens 62 Thrombin 62 IRX 2 62 ® lenalidomide 62 histone deacetylase HDAC inhibitor 62 Genasense R oblimersen 62 selective androgen receptor modulator 62 factor HGF 62 R#/MEM # 62 Aptivus ® 62 beta 1a 62 custirsen 62 punctal plug 62 p# inhibitor 62 Beta catenin pathway 62 Nexavar sorafenib 62 insulin glulisine 62 transgene expression 62 Phase Ib clinical 62 L asparaginase 62 phase IIa clinical 62 transthyretin TTR mediated amyloidosis 62 NEUGENE 62 GTC recombinant human 62 trastuzumab Herceptin ® 62 DAPT 62 NN# [001] 62 Novolimus 62 saline placebo 62 ANAVEX #-# [002] 62 Hepatocellular Carcinoma HCC 62 veltuzumab 62 GnRH antagonist 62 HDAC inhibition 62 mGluR2 NAM 62 ARIKACE ™ 62 lucinactant 62 Interferon beta 62 AEGR 62 CYP#A# substrate 62 inhaled liposomal ciprofloxacin 62 BCX# 62 Darusentan 62 bile acid sequestrant 62 rFIXFc 62 antiangiogenic 62 haematologic 62 LAB CGRP 62 angiogenesis inhibitor 62 FOLOTYN ® 62 novel histone deacetylase 62 BeneFIX 62 itraconazole 62 Blinatumomab 62 rBChE 62 tiuxetan 62 R baclofen 62 LB# [003] 62 gemcitabine carboplatin 62 flutamide 62 Omacetaxine mepesuccinate 62 Dacogen injection 62 voriconazole 62 pan HDAC inhibitor 62 leukotriene receptor antagonist 62 HMG CoA reductase inhibitors 62 Q#IR 62 p# alpha [001] 62 CD# monoclonal antibody 62 pharmacodynamic parameters 62 idraparinux 62 TYZEKA 62 Mipomersen 62 Resten NG 62 intravenously administered 62 Panzem NCD 62 K ras mutations 62 cynomolgus monkeys 62 OMNARIS HFA 62 anti angiogenic agents 62 prokinetic agent 62 PCK# 62 orally administered inhibitor 62 C1 INH 62 vasodilatory 62 bioscavenger 62 E1 INT TM 62 RRM1 62 Natalizumab 62 Temsirolimus 62 tezampanel NGX# 62 vivo potency 62 Recombinant Human 62 BENICAR HCT 62 Cytarabine 62 alpha 2a 62 liposome encapsulated 62 serum phosphorous 62 triphendiol 62 Ophena TM 62 direct thrombin inhibitors 62 JAK#/JAK# 62 hematological parameters 62 compound AEZS 62 tanespimycin 62 redox active 62 intratumoral 62 xanthine oxidase inhibitor 62 superficial bladder cancer 62 radezolid 62 XmAb# 62 liposome formulation 62 ERK pathway 62 HspE7 62 thymidylate synthase TS 62 Phase #b/#a clinical 62 FluCide 62 BRAF kinase 62 intravesical 62 noscapine 62 glatiramer 62 Quinamed 62 LymphoStat B TM 62 paraprotein 62 PI3K/Akt pathway inhibitor 62 partial remissions 62 isoproterenol 62 Camptosar ® 62 alpha#beta# integrin 62 enzyme cofactor 62 oral methylnaltrexone 62 prostate carcinoma 62 samalizumab 62 immunomodulatory therapy 62 ritonavir boosting 62 tubulin inhibitor 62 oral deforolimus 62 dose dependently 62 vivo validation 62 Golimumab 62 tolerability pharmacokinetics 62 proteasome inhibitors 62 IMA# 62 ISF# 62 Antitumor 61 intratumoral injection 61 5 fluorouracil leucovorin 61 xenograft 61 R Saizen R 61 SERCA2a 61 unconjugated 61 siRNA therapeutic 61 somatostatin 61 trospium 61 BEXXAR 61 clevudine 61 Phase Ib II 61 sipuleucel T 61 subcutaneous immunoglobulin 61 pamidronate 61 RSD# oral 61 HuMax 61 docetaxel Taxotere 61 epratuzumab 61 humanized anti 61 Radilex 61 non nucleoside HCV 61 effector function 61 mg kg dose 61 tinzaparin 61 thymalfasin 61 potently inhibit 61 intravenous immunoglobulin IVIG 61 leukemia AML 61 CIMZIA R 61 preclinical pharmacokinetic 61 gastrointestinal stromal tumors GISTs 61 systemic RNAi therapeutic 61 E2F Decoy 61 ara C 61 Lenocta 61 plasma pharmacokinetics 61 Genasense ® oblimersen 61 cidofovir 61 CCR5 antagonist 61 transgenic rats 61 HIF PH inhibitors 61 bicalutamide 61 Ganciclovir 61 crizotinib PF # 61 heparanase 61 imatinib Gleevec 61 cytostatic 61 Aloxi injection 61 Vacc 4x 61 Zalypsis 61 #mg dose [001] 61 RhuDex ® 61 Xcellerated T Cells 61 ribavirin RBV 61 Capecitabine 61 cyclophosphamide methotrexate 61 Fc receptor 61 LNP formulations 61 Leukine ® 61 MYLOTARG 61 antiangiogenic agent 61 Annamycin 61 Microplasmin 61 Altastaph 61 inhibiting tumor 61 antiangiogenic activity 61 adrenocorticotropic hormone ACTH 61 ADAMTS# 61 LEUKINE 61 catheter occlusion 61 GAP #B# 61 BoNTA 61 interferon IFN 61 hormone LHRH antagonist 61 Archexin 61 baminercept 61 selective agonists 61 OADs 61 cobiprostone 61 sunitinib Sutent 61 TELCYTA 61 antifibrotic 61 antibody MAb 61 Janus Kinase 61 potent suppressor 61 PNP inhibitor 61 Antiangiogenic 61 PEP# [003] 61 rhIGF-I/rhIGFBP-3 61 2DG 61 antiproliferative 61 Epothilones 61 Fludarabine 61 TO AVOID PREGNANCY WHILE 61 rFSH 61 Hsp# inhibitor 61 Vaxfectin R 61 micafungin 61 MyVax ® 61 Prolongs Survival 61 Enzastaurin 61 metastatic neuroendocrine tumors 61 CCR9 antagonist 61 Aflibercept 61 RiVax 61 intravenous immunoglobulin 61 HepG2 cells 61 Deforolimus 61 basiliximab 61 rindopepimut 61 Cloretazine VNP#M 61 Vorinostat 61 Phase IIIb clinical 61 Personalized Immunotherapy 61 prostate epithelial cells 61 CTAP# Capsules 61 incyclinide 61 Sym# 61 radiolabeled 61 polyclonal 61 humanized antibody 61 DEB# 61 motilin 61 receptor blocker 61 TNFa 61 decitabine 61 Inhalation Solution 61 Lisofylline 61 metastatic colorectal 61 DURIN TM 61 opioid analgesia 61 baseline LDH 61 liposomal 61 Fodosine 61 FUS1 61 vWF 61 BRIM2 61 FVIIa 61 Civacir 61 GVAX ® 61 refractory chronic lymphocytic 61 MAb 61 brivaracetam 61 pentostatin 61 CANCIDAS 61 ganciclovir 61 Alferon N 61 vismodegib 61 EGFR TKI 61 Ventavis ® 61 HDAC Inhibitor 61 Hematologic 61 oral ridaforolimus 61 wilate ® 61 suppresses tumor 61 CIPN 61 Zoledronic acid 61 Preclinical studies 61 aldehyde dehydrogenase ALDH2 deficiency 61 plasma kallikrein 61 PORxin TM 61 Pivotal Phase III 61 PrevOnco ™ 61 plasmid DNA vaccine 61 TACI Ig 61 davunetide intranasal AL 61 HbF 61 assessing T DM1 61 enzastaurin 61 low dose cytarabine 61 rhITF 61 OvaRex ® MAb 61 CytoFabTM 61 neuro protective 61 peripherally acting 61 Urokinase 61 p# biomarker 61 sodium thiosulfate STS 61 SPC# [001] 61 oral talactoferrin 61 nanopharmaceutical 61 sd rxRNA 61 interferon alpha 2b 61 rHuEPO 61 acyclovir Lauriad R 61 corticosteroid therapy 61 TGF beta1 61 adjuvant cisplatin 61 CDP# 61 anthracycline chemotherapy 61 epirubicin 61 TRX1 61 PROSTVAC VF 61 imexon 61 adenoviral 61 albiglutide 61 steroid refractory 61 paricalcitol 61 MDS AML 61 GLP1 agonist 61 Akt activation 61 immunomodulatory effects 61 MET amplification 61 Saforis 61 cyclic peptide 61 orthotopic 61 orthotopic model 61 reversible inhibitor 61 urothelial bladder cancer 61 rFVIII 61 CD# expressing 61 Phase IIB 61 JAK inhibitors 61 recombinant erythropoietin 61 VA# [002] 61 pharmacologically active isomer 61 polymerase inhibitor 61 LHRH 61 immunoconjugate 61 Phase 2b Clinical Trial 61 recombinant factor VIIa 61 SYN# 61 JAK2 inhibitors 61 INTEGRILIN 61 MP4OX 61 EXPAREL TM 61 ACV1 61 telomerase therapeutic 61 ZFP TF 61 CD8 + cytotoxic 61 NEUPOGEN 61 SCIg 61 adriamycin 61 clevidipine 61 intracellular uptake 61 vapreotide acetate 61 levodopa carbidopa 61 IFN ß 61 gemcitabine Gemzar 61 cysteamine bitartrate 61 Allovectin 7 61 ibritumomab tiuxetan 61 synthetic retinoid 61 LEX System 61 IV Busulfex 61 Amino acid 61 pharmacokinetic interactions 61 entinostat 61 paclitaxel cisplatin 61 multitargeted 61 trastuzumab Herceptin R 61 small molecule Hedgehog 61 Fx #A 61 IMiDs 61 Privigen 61 collagenase 61 SNALP technology 61 Aganocide 61 antioxidant supplementation 61 Ecallantide 61 ACAPODENE TM 61 rNAPc2 61 accumulate preferentially 61 Clusterin 61 Pharmacodynamic 61 Telbivudine 61 pharmacodynamic effects 61 Proxinium TM 61 Intravail R 61 inhibit replication 61 PD LID 61 small molecule tyrosine 61 virus HCV protease inhibitor 61 TRAIL receptor antibodies